^
6ms
Non-Cytotoxic Photodynamic Therapy with Talaporfin Sodium Reduces the Expression of CXCR4 and Enhances Chemotherapeutic Efficacy in Undifferentiated Gastric Cancer Cell Line HGC27. (PubMed, Acta Histochem Cytochem)
These findings highlight the potential of non-cytotoxic TS-PDT as a synergistic treatment approach. We conclude that non-cytotoxic TS-PDT could enhance drug sensitivity and offers a promising therapeutic strategy for GC.
Preclinical • Journal
|
CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
Litx (talaporfin)
11ms
Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy. (PubMed, Int Immunol)
These beneficial effects of Tal-PDT on anti-tumor immunity collectively enhance ICB cancer immunotherapy. Our study demonstrates the potential of combining Tal-PDT with ICB therapy for clinical applications.
Journal
|
CD8 (cluster of differentiation 8)
|
Litx (talaporfin)
1year
Screening of photosensitizers-ATP binding cassette (ABC) transporter interactions in vitro. (PubMed, Cancer Drug Resist)
The ABCG2 inhibitor (fumitremorgin C) and P-gp inhibitor (valspodar) effectively blocked the transport mediated by ABCG2 and P-gp of rose bengal and BPD... In summary, our study provided new knowledge that temoporfin, talaporfin sodium, methylene blue, and indocyanine green are not substrates of ABCG2, P-gp, or MRP1...Rose bengal is a substrate of ABCG2, P-gp, and MRP1. The results presented here indicate ABC transporter substrate status as a possible cause for cellular resistance to photodynamic therapy with rose bengal, redaporfin, and BPD.
Preclinical • Journal
|
ABCB1 (ATP Binding Cassette Subfamily B Member 1) • ABCG2 (ATP Binding Cassette Subfamily G Member 2) • ABCC1 (ATP Binding Cassette Subfamily C Member 1)
|
Foscan (temoporfin) • Litx (talaporfin)
over1year
Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models. (PubMed, Nano Lett)
This prodrug activation results in the degradation of the target protein BRD4, while simultaneously reversing the upregulation of PD-L1 expression associated with the SDT process. In the orthotopic mouse model of pancreatic tumors, NPCe6+PRO effectively suppressed tumor growth in conjunction with US stimulation.
Preclinical • Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • BRD4 (Bromodomain Containing 4)
|
Litx (talaporfin)
2years
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers. (PubMed, J Gastroenterol)
This study found that the mechanism underlying TS-PDT-induced ferroptosis constitutes direct lipid peroxidation by the generated ROS, and the inhibition of system xc, and that the combination of a ferroptosis inducer with TS-PDT enhances the antitumor effect of TS-PDT. Our findings suggest that ferroptosis-inducing therapies combined with PDT may benefit cancer patients.
Journal
|
GPX4 (Glutathione Peroxidase 4)
|
sorafenib • erastin • RSL3 • Litx (talaporfin)
2years
Novel chlorin e-based conjugates of tyrosine kinase inhibitors: Synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy. (PubMed, Eur J Med Chem)
Since tyrosine kinase inhibitor (TKI) could reverse ABCG2-mediated drug-resistance, novel chlorin e-based conjugates of Dasatinib and Imatinib as photosensitizer (PS) were designed and synthesized. It could reduce efflux of intracellular PS by inhibiting ABCG2 in HepG2 cells, and localize in mitochondria, lysosomes, golgi and ER, resulting in higher cell apoptosis rate and ROS production than Talaporfin. Moreover, it could induce cell autophagy and block cell cycle in S phase, and significantly inhibit tumor growth and prolong survival time on BALB/c nude mice bearing HepG2 xenograft tumor to a greater extent than chlorin e. Consequently, compound 10b could be applied as a promising candidate PS due to its good water-solubility and stability, low drug-resistance, high quantum yield of O and excellent antitumor efficacy in vitro and in vivo.
Journal
|
ABCG2 (ATP Binding Cassette Subfamily G Member 2)
|
dasatinib • imatinib • Litx (talaporfin)
2years
Photosensitizers for Photodynamic Therapy of Brain Cancers-A Review. (PubMed, Brain Sci)
The most commonly used photosensitizers include 5-aminolevulinic acid for the enzymatic generation of protoporphyrin IX, Temoporfin-THPC, Photofrin, Hypericin and Talaporfin. An overview of all three generations of photosensitizers is presented. Along with an indication of the limitations of the treatment of brain tumors, intraoperative photodynamic therapy and its possibilities are described as an alternative therapeutic method.
Review • Journal
|
Foscan (temoporfin) • Litx (talaporfin) • Photofrin (porfimer sodium)
over2years
Clinical Impact of the Charlson Comorbidity Index on the Efficacy of Salvage Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer. (PubMed, Intern Med)
The rate of an L-CR (p=0.035) and the 2-year PFS (p=0.029) and OS (p=0.018) rates in the CCI ≥1 group were significantly lower than those in the CCI=0 group. Conclusion This study found that the CCI was negatively associated with the efficacy of salvage TS-PDT for esophageal cancer.
Journal
|
Litx (talaporfin)
over2years
Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives. (PubMed, Cancers (Basel))
Trastuzumab emtansine demonstrated higher antiproliferative activity in CCA cells expressing higher levels of HER2...Hematoporphyrin derivatives, temoporfin, phthalocyanine-4, talaporfin, and chlorine e6 derivatives have mainly been used clinically and preclinically in bile duct cancer...Future human and artificial intelligence collaboration has potential for overcoming challenges related to identifying universal CCA cell targets. This could pave the way for highly targeted therapies for CCA, such as ADC, PDT, and PIT.
Review • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • MUC1 (Mucin 1)
|
HER-2 expression
|
Kadcyla (ado-trastuzumab emtansine) • Foscan (temoporfin) • Litx (talaporfin)